Gaebler-Spira Deborah, Revivo Gadi
Pediatric Rehabilitation Program, The Rehabilitation Institute of Chicago, 345 E. Superior Street, Chicago, IL 60611, USA.
Phys Med Rehabil Clin N Am. 2003 Nov;14(4):703-25. doi: 10.1016/s1047-9651(03)00043-3.
Botulinum toxins have an exciting and important role in treating the child with hypertonia. The guidelines presented in this article are those that have been published representing the safe use of botulinum toxins in children. Experience and a decade of research have provided the framework for using botulinum toxins in decreasing deformity and promoting function. In children, a window of opportunity exists with botulinum toxin that allows improved motor control and elongation of shortened muscles. Although 3 to 4 months in an adult life is short, for a child it is a relatively greater proportion of their life experience and may be long enough for skill development. The improvement noted in function after botulinum toxin use is facilitated by comprehensive rehabilitation. The pediatric physiatrist has a unique role in the management of children with cerebral palsy and other conditions with hypertonia. Their knowledge and training reflect an understanding of anatomy and development that allows accurate evaluation of specific functional problems in children related to hypertonia. The pediatric physiatrist has experience in localization of muscles by EMG, nerve stimulation, and surface anatomy. Although many other physicians inject botulinum toxins, goal-directed management is the cornerstone to the physiatrist's thinking and treatment plan. Orthopedic surgery ultimately may be the intervention of choice if persistent contracture or progression of contractures occurs. Working in collaboration with an orthopedist identifies the timing of optimal surgical intervention for alignment. For persistent and severe hypertonia, the treatment team includes a neurosurgeon. All options for spasticity, such as selective posterior rhizotomy and intrathecal baclofen, should be considered. Re-evaluation of the child after selective dorsal rhizotomy or intrathecal baclofen is appropriate and should be discussed with therapists for focal intervention. Communication between members of the team and the family is desirable and frequently is one of the major contributions of the pediatric physiatrist. For children with focal hypertonia, botulinum toxins offer a dramatic but temporary repeatable change that affects rehabilitation. Research rapidly has captured the positive effect of the toxins on impairment and functional limitations. Not to be overlooked are outcomes related to quality of life. The long-term use of botulinum toxins and the role the toxins play throughout the life span of the person with a childhood hypertonic disorder are yet to be determined.
肉毒杆菌毒素在治疗儿童肌张力亢进方面发挥着令人兴奋且重要的作用。本文所呈现的指南是已发表的关于儿童安全使用肉毒杆菌毒素的指南。经验以及十年的研究为使用肉毒杆菌毒素减少畸形和促进功能提供了框架。在儿童中,肉毒杆菌毒素存在一个机会窗口,可改善运动控制并延长缩短的肌肉。虽然在成年人的生活中3至4个月很短,但对儿童来说,这在他们的生活经历中占比相对更大,可能足以促进技能发展。肉毒杆菌毒素使用后功能的改善通过综合康复得以促进。儿科物理治疗师在管理患有脑瘫和其他肌张力亢进病症的儿童方面具有独特作用。他们的知识和培训体现了对解剖学和发育的理解,从而能够准确评估与儿童肌张力亢进相关的特定功能问题。儿科物理治疗师具有通过肌电图、神经刺激和表面解剖定位肌肉的经验。尽管许多其他医生也注射肉毒杆菌毒素,但目标导向的管理是物理治疗师思考和治疗计划的基石。如果出现持续性挛缩或挛缩进展,骨科手术最终可能是首选干预措施。与骨科医生合作可确定最佳手术矫正时机。对于持续性和严重的肌张力亢进,治疗团队应包括神经外科医生。应考虑所有治疗痉挛的选择,如选择性后根切断术和鞘内注射巴氯芬。在选择性背根切断术或鞘内注射巴氯芬后对儿童进行重新评估是合适的,并且应与治疗师讨论进行局部干预。团队成员与家庭之间的沟通是可取的,这通常是儿科物理治疗师的主要贡献之一。对于患有局部肌张力亢进的儿童,肉毒杆菌毒素提供了一种显著但暂时且可重复的变化,会影响康复。研究迅速捕捉到了毒素对损伤和功能限制的积极影响。与生活质量相关的结果也不应被忽视。肉毒杆菌毒素的长期使用以及毒素在患有儿童期高渗性疾病患者整个生命周期中所起的作用尚待确定。